Animal and Translational Models for CNS Drug DiscoveryEdited by
- Robert McArthur
- Franco Borsini
Minimize the number of drug candidates that could later fail in human trials! These three volumes provide a unique examination of how animal models are evolving from ?behavioral gut baths? to providing cross-species information relevant to human clinical responses. Each volume provides the views and experiences of leading pre-clinical and clinical investigators who are actively involved in translational research and experimental medicine.Each volume is devoted to specific disorders in three scientific fields: Psychiatric, Neurological, and Reward Deficit.
Academic neuroscientists involved in the development and use of animal models of neuropsychiatric disorders to study their basic neurobiology; Academic and pharmaceutical neuroscientists involved in the use of animal models of neuropsychiatric disorders to identify and validate novel targets for potential pharmaceutical treatment of these disorders; Clinical and translational neuroscientists concerned with limitations of present neuropsychiatric clinical trial designs, development of valid biomarkers and cross-species; and Pharmaceutical industry, regulatory body and venture capital executives concerned with improvements in the attrition rate of CNS drug candidates.